Radiotherapy for single station N2 NSCLCRadiotherapy for single station N2 NSCLC
Faculty of Medicine and Health Sciences
Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO)
Translational lung cancer research. - -
3(2014):4, p. 234-237
University of Antwerp
Clinical single station N2 is a prognostic factor, which is only moderately identifiable preoperatively, even after adequate mediastinal staging. There is little evidence that single station N2 predicts for the outcome of any radical treatment strategy, or for a benefit of postoperative radiotherapy. In adequately staged patients with clinical single station N2 involvement, modern definitive chemoradiation therapy results in equivalent outcome as induction therapy followed by resection.